Biologic 0 8 0 8 B-treatment
( 9 10 9 10 I-treatment
anti 10 14 10 14 I-treatment
- 14 15 14 15 I-treatment
neoplastic 15 25 15 25 I-treatment
agent 26 31 26 31 I-treatment
): 31 33 31 33 I-treatment
7 34 35 34 35 O
day 36 39 36 39 O
must 40 44 40 44 O
have 45 49 45 49 O
elapsed 50 57 50 57 O
from 58 62 58 62 O
the 63 66 63 66 O
start 67 72 67 72 O
of 73 75 73 75 O
protocol 76 84 76 84 B-treatment
therapy 85 92 85 92 I-treatment
since 93 98 93 98 O
the 99 102 99 102 O
completion 103 113 103 113 O
of 114 116 114 116 O
therapy 117 124 117 124 B-treatment
with 125 129 125 129 I-treatment
a 130 131 130 131 I-treatment
biologic 132 140 132 140 I-treatment
agent 141 146 141 146 I-treatment

Concomitant 0 11 147 158 B-treatment
Medications 12 23 159 170 I-treatment
: 23 24 170 171 O
The 25 28 172 175 O
metabolism 29 39 176 186 O
of 40 42 187 189 O
paclitaxel 43 53 190 200 B-treatment
is 54 56 201 203 O
catalyzed 57 66 204 213 O
by 67 69 214 216 O
CYP2C8 70 76 217 223 B-treatment
and 77 80 224 227 O
CYP3A4 81 87 228 234 B-treatment

Hematopoietic 0 13 235 248 O
growth 14 20 249 255 O
factors 21 28 256 263 O
: 28 29 263 264 O
7 30 31 265 266 O
days 32 36 267 271 O
must 37 41 272 276 O
have 42 46 277 281 O
elapsed 47 54 282 289 O
from 55 59 290 294 O
the 60 63 295 298 O
start 64 69 299 304 O
of 70 72 305 307 O
protocol 73 81 308 316 O
therapy 82 89 317 324 O
since 90 95 325 330 O
the 96 99 331 334 O
completion 100 110 335 345 O
of 111 113 346 348 O
therapy 114 121 349 356 B-treatment
with 122 126 357 361 I-treatment
filgrastim 127 137 362 372 I-treatment
, 137 138 372 373 O
and 139 142 374 377 O
14 143 145 378 380 O
days 146 150 381 385 O
must 151 155 386 390 O
have 156 160 391 395 O
elapsed 161 168 396 403 O
from 169 173 404 408 O
the 174 177 409 412 O
start 178 183 413 418 O
of 184 186 419 421 O
protocol 187 195 422 430 O
therapy 196 203 431 438 O
after 204 209 439 444 O
receiving 210 219 445 454 O
pegfilgrastim 220 233 455 468 B-treatment

Men 0 3 469 472 B-gender
treated 4 11 473 480 O
or 12 14 481 483 O
enrolled 15 23 484 492 O
on 24 26 493 495 O
this 27 31 496 500 O
protocol 32 40 501 509 O
must 41 45 510 514 O
also 46 50 515 519 O
agree 51 56 520 525 B-contraception_consent
to 57 59 526 528 I-contraception_consent
use 60 63 529 532 I-contraception_consent
adequate 64 72 533 541 I-contraception_consent
contraception 73 86 542 555 I-contraception_consent
4 87 88 556 557 B-upper_bound
months 89 95 558 564 I-upper_bound
after 96 101 565 570 O
completion 102 112 571 581 O
of 113 115 582 584 O
gemcitabine 116 127 585 596 B-treatment
and 128 131 597 600 O
nab 132 135 601 604 B-treatment
- 135 136 604 605 I-treatment
paclitaxel 136 146 605 615 I-treatment
administration 147 161 616 630 O

Must 0 4 631 635 O
not 5 8 636 639 O
have 9 13 640 644 O
received 14 22 645 653 O
prior 23 28 654 659 B-treatment
therapy 29 36 660 667 I-treatment
with 37 41 668 672 O
either 42 48 673 679 O
gemcitabine 49 60 680 691 B-treatment
or 61 63 692 694 O
nab 64 67 695 698 B-treatment
- 67 68 698 699 I-treatment
paclitaxel 68 78 699 709 I-treatment

Myelosuppressive 0 16 710 726 B-treatment
chemotherapy 17 29 727 739 I-treatment
: 29 30 739 740 O
Must 31 35 741 745 O
not 36 39 746 749 O
have 40 44 750 754 O
received 45 53 755 763 O
myelosuppressive 54 70 764 780 B-treatment
chemotherapy 71 83 781 793 I-treatment
within 84 90 794 800 O
3 91 92 801 802 B-upper_bound
weeks 93 98 803 808 I-upper_bound
of 99 101 809 811 O
protocol 102 110 812 820 O
therapy 111 118 821 828 O
on 119 121 829 831 O
this 122 126 832 836 O
study 127 132 837 842 O

Neuropathy 0 10 843 853 O
: 10 11 853 854 O
Must 12 16 855 859 O
have 17 21 860 864 O
â‰¤ 22 23 865 866 O
grade 24 29 867 872 B-upper_bound
1 30 31 873 874 I-upper_bound
neuropathy 32 42 875 885 O
at 43 45 886 888 O
enrollment 46 56 889 899 O

Potential 0 9 900 909 O
participants 10 22 910 922 O
with 23 27 923 927 O
known 28 33 928 933 O
CNS 34 37 934 937 B-cancer
metastases 38 48 938 948 I-cancer
are 49 52 949 952 O
excluded 53 61 953 961 O
unless 62 68 962 968 O
treated 69 76 969 976 O
surgically 77 87 977 987 O
or 88 90 988 990 O
with 91 95 991 995 O
radiotherapy 96 108 996 1008 B-treatment
and 109 112 1009 1012 O
stable 113 119 1013 1019 O
with 120 124 1020 1024 O
no 125 127 1025 1027 O
recurrent 128 137 1028 1037 O
lesions 138 145 1038 1045 O
for 146 149 1046 1049 O
at 150 152 1050 1052 O
least 153 158 1053 1058 O
3 159 160 1059 1060 B-lower_bound
months 161 167 1061 1067 I-lower_bound
from 168 172 1068 1072 O
the 173 176 1073 1076 O
start 177 182 1077 1082 O
of 183 185 1083 1085 O
protocol 186 194 1086 1094 O
therapy 195 202 1095 1102 O

Radiotherapy 0 12 1103 1115 B-treatment
: 12 13 1115 1116 O
2 14 15 1117 1118 O
weeks 16 21 1119 1124 O
must 22 26 1125 1129 O
have 27 31 1130 1134 O
elapsed 32 39 1135 1142 O
from 40 44 1143 1147 O
the 45 48 1148 1151 O
start 49 54 1152 1157 O
of 55 57 1158 1160 O
protocol 58 66 1161 1169 B-treatment
therapy 67 74 1170 1177 I-treatment
since 75 80 1178 1183 O
local 81 86 1184 1189 O
palliative 87 97 1190 1200 B-treatment
radiotherapy 98 110 1201 1213 I-treatment
( 111 112 1214 1215 O
small 112 117 1215 1220 O
port 118 122 1221 1225 O
) 122 123 1225 1226 O

Stem 0 4 1227 1231 B-treatment
Cell 5 9 1232 1236 I-treatment
Transplant 10 20 1237 1247 I-treatment
or 21 23 1248 1250 O
Rescue 24 30 1251 1257 O
: 30 31 1257 1258 O
No 32 34 1259 1261 O
evidence 35 43 1262 1270 O
of 44 46 1271 1273 O
active 47 53 1274 1280 O
graft 54 59 1281 1286 O
vs. 60 63 1287 1290 O
host 64 68 1291 1295 O
disease 69 76 1296 1303 O
and 77 80 1304 1307 O
2 81 82 1308 1309 O
months 83 89 1310 1316 O
must 90 94 1317 1321 O
have 95 99 1322 1326 O
elapsed 100 107 1327 1334 O
from 108 112 1335 1339 O
the 113 116 1340 1343 O
start 117 122 1344 1349 O
of 123 125 1350 1352 O
protocol 126 134 1353 1361 O
therapy 135 142 1362 1369 O
since 143 148 1370 1375 O
transplant 149 159 1376 1386 O

Women 0 5 1387 1392 B-gender
of 6 8 1393 1395 O
child 9 14 1396 1401 O
- 14 15 1401 1402 O
bearing 15 22 1402 1409 O
potential 23 32 1410 1419 O
and 33 36 1420 1423 O
men 37 40 1424 1427 O
must 41 45 1428 1432 O
agree 46 51 1433 1438 B-contraception_consent
to 52 54 1439 1441 I-contraception_consent
use 55 58 1442 1445 I-contraception_consent
adequate 59 67 1446 1454 I-contraception_consent
contraception 68 81 1455 1468 I-contraception_consent
prior 82 87 1469 1474 O
to 88 90 1475 1477 O
study 91 96 1478 1483 O
entry 97 102 1484 1489 O
and 103 106 1490 1493 O
for 107 110 1494 1497 O
the 111 114 1498 1501 O
duration 115 123 1502 1510 O
of 124 126 1511 1513 O
study 127 132 1514 1519 O
participation 133 146 1520 1533 O

cardiac 0 7 1534 1541 B-chronic_disease
arrhythmia 8 18 1542 1552 I-chronic_disease

have 0 4 1553 1557 O
had 5 8 1558 1561 O
a 9 10 1562 1563 O
histologic 11 21 1564 1574 O
diagnosis 22 31 1575 1584 O
of 32 34 1585 1587 O
osteosarcoma 35 47 1588 1600 B-cancer
, 47 48 1600 1601 O
Ewing 49 54 1602 1607 B-cancer
sarcoma 55 62 1608 1615 I-cancer
, 62 63 1615 1616 O
or 64 66 1617 1619 O
rhabdomyosarcoma 67 83 1620 1636 B-cancer
or 84 86 1637 1639 O
non 87 90 1640 1643 O
- 90 91 1643 1644 O
rhabdomyosarcoma 91 107 1644 1660 B-cancer
soft 108 112 1661 1665 I-cancer
tissue 113 119 1666 1672 I-cancer
sarcoma 120 127 1673 1680 I-cancer
either 128 134 1681 1687 O
at 135 137 1688 1690 O
diagnosis 138 147 1691 1700 O
or 148 150 1701 1703 O
relapse 151 158 1704 1711 O

history 0 7 1712 1719 O
of 8 10 1720 1722 O
allergic 11 19 1723 1731 O
reactions 20 29 1732 1741 O
attributed 30 40 1742 1752 O
to 41 43 1753 1755 O
docetaxel 44 53 1756 1765 B-allergy_name
or 54 56 1766 1768 O
paclitaxel 57 67 1769 1779 B-allergy_name

ongoing 0 7 1780 1787 O
or 8 10 1788 1790 O
active 11 17 1791 1797 B-chronic_disease
infection 18 27 1798 1807 I-chronic_disease

psychiatric 0 11 1808 1819 B-chronic_disease
illness 12 19 1820 1827 I-chronic_disease
/ 19 20 1827 1828 I-chronic_disease
social 20 26 1828 1834 I-chronic_disease
situations 27 37 1835 1845 I-chronic_disease
that 38 42 1846 1850 O
would 43 48 1851 1856 O
limit 49 54 1857 1862 O
compliance 55 65 1863 1873 O
with 66 70 1874 1878 O
study 71 76 1879 1884 O
requirements 77 89 1885 1897 O

symptomatic 0 11 1898 1909 B-chronic_disease
congestive 12 22 1910 1920 I-chronic_disease
heart 23 28 1921 1926 I-chronic_disease
failure 29 36 1927 1934 I-chronic_disease

unstable 0 8 1935 1943 O
angina 9 15 1944 1950 B-chronic_disease
pectoris 16 24 1951 1959 I-chronic_disease

